   
alabama
BILL # No known legislation existing or recently introduced.
alaska
BILL # HB 218
SPONS. Representative B. Thomas
STATUS DEAD
PURPOSE Requires that patients are given 90 days notice prior to a drug being put in specialty tier pricing before imposing any cost sharing obligations.
arizona
BILL # SB 1594
SPONS. Senators Barto, Driggs, McComish, Murphy and Representative D. Smith
STATUS DEAD
PURPOSE Drug cannot be reclassified to another tier during the term of the contract, and if they are to be reclassified insurers must give at least 60-days notice.
arkansas
BILL # No known legislation existing or recently introduced.
california
BILL # No known legislation existing or recently introduced.
colorado
BILL # No known legislation existing or recently introduced.
connecticut
BILL # SB 1084
SPONS. Senator Joseph Crisco
STATUS DEAD
PURPOSE Prohibits insurers from imposing a greater coinsurance, copayment, deductible or other out-of-pocket expense for nonpreferred brand name drugs than for preferred brand name drugs.
delaware
SPONS. Sen. Henry & Rep. Barbieri Sens. Blevins, Hall-Long & Peterson; Reps. Q. Johnson, Keeley, D.E. Williams & Bolden
STATUS ACTIVE
PURPOSE One year moratorium and study. Delaware Healthcare Commission shall conduct a study for specialty tier prescription drugs to determine the impact on access and patient care. The Delaware Healthcare Commission shall submit a report to the General Assembly summarizing this impact by March 15, 2012.
florida
BILL # No known legislation existing or recently introduced.
georgia
BILL # No known legislation existing or recently introduced.
hawaii
BILL # SCR 93
SPONS. Senators Nishihara, J. Green, Shimabukuro, Baker, Oakland, and Espero
STATUS DEAD
PURPOSE Resolution discouraging the use of specialty tiers, stating it should be avoided or eliminated where possible.
idaho
BILL # No known legislation existing or recently introduced.
illinois
BILL # HR 450
SPONS. Representative Jehan A. Gordon
STATUS ACTIVE
PURPOSE Resolution requesting the Department of Insurance to study the impacts of cost sharing, coinsurance, and specialty-tier pricing for prescription medications, determine effects of these things on access to medications, and identify ways to reduce any negative impacts of such pricing.
indiana BILL # SB 178
SPONS. Senator Patricia Miller
STATUS ACTIVE
PURPOSE Requires an interim study on "substitutions", which refers to the substitution of a drug, device, or therapy.
iowa
BILL # No known legislation existing or recently introduced.
kansas
BILL # No known legislation existing or recently introduced.
kentucky
BILL # No known legislation existing or recently introduced.
louisiana
BILL # No known legislation existing or recently introduced.
maine
BILL # No known legislation existing or recently introduced.
maryland
BILL # HB 251
SPONS. Delegates Shirley Nathan-Pulliam and Joseline Pena-Melnyk
STATUS DEAD
PURPOSE Limits the amount of cost-sharing an insurer can charge for a month's supply of a covered prescription to $100, however the limit does not apply to a brand name drug for which a generic equivalent is available. (Defeated due to fiscal note).
massachusetts
BILL # No known legislation existing or recently introduced.
michigan
BILL # No known legislation existing or recently introduced.
minnesota
BILL # No known legislation existing or recently introduced.
mississippi
BILL # No known legislation existing or recently introduced.
missouri
BILL # No known legislation existing or recently introduced.
montana
BILL # No known legislation existing or recently introduced.
nebraska
BILL # No known legislation existing or recently introduced.
nevada
LEGIS. No known legislation existing or recently introduced.
new hampshire
BILL # No known legislation existing or recently introduced.
new jersey
BILL # No known legislation existing or recently introduced.
new mexico
BILL # SB 536
SPONS. Senator Tim Jennings
STATUS DEAD
PURPOSE Cost sharing obligations cannot be imposed that exceed the cost of a non-preferred brand drug/equivalent or a brand drug if there is no non-preferred category and if a drug is going to be moved to a higher tier the insurer must give 60-days notice, and it cannot be moved during the term of the contract.
new york
BILL # S68004-2009
SPONS. Assemblymember Micah Kellner
STATUS ACTIVE
PURPOSE Amends the public health and insurance laws to prohibit cost- sharing imposed on patients.
north carolina
BILL # No known legislation existing or recently introduced.
north dakota
BILL # No known legislation existing or recently introduced.
ohio
BILL # No known legislation existing or recently introduced.
oklahoma
BILL # No known legislation existing or recently introduced.
oregon
BILL # No known legislation existing or recently introduced.
pennsylvania
BILL # No known legislation existing or recently introduced.
rhode island
BILL # No known legislation existing or recently introduced.
south carolina
BILL # No known legislation existing or recently introduced.
south dakota
BILL # No known legislation existing or recently introduced.
tennessee
BILL # No known legislation existing or recently introduced.
texas
BILL # HB 1405
SPONS. Representative John T. Smithee
STATUS ACTIVE
PURPOSE Requires notice to consumers for any modifications affecting drug coverage including moving a drug to a higher cost- sharing tier, unless a generic alternative to the drug is available.
utah
BILL # No known legislation existing or recently introduced.
vermont
BILL # SB 104
SPONS. Senate Committee on Health and Welfare
STATUS ACTIVE
PURPOSE Creates a one-year moratorium on specialty tiers, prohibiting any health insurer or pharmacy benefits manager from utilizing a cost-sharing structure for prescription drugs that imposes a greater co-pay, deductible, coinsurance, or other cost-sharing requirement on the consumer than which applies to non-preferred brand-name drugs.
virginia
BILL # HR 579
SPONS. Delegate John O'Bannon
STATUS ACTIVE
PURPOSE Directs the Joint Commission on Health Care to study the impacts of cost sharing, coinsurance, specialty tier pricing for prescription medications.
washington
BILL # HB 1876
SPONS. Representatives Gutierrez-Kenny and Green
STATUS DEAD
PURPOSE Adding to the insurance code requiring that an insurer cannot charge more than 500% the lowest prescription co- pay charged under the plan and if the plan creates a limit on out-of-pocket expenses then expenses for prescription drugs may not exceed $1000 a year for individuals and $2000 for families, adjusted for inflation.
west virginia
BILL # SR 71
SPONS. Senators Hall, McCabe, Minard and Browning
STATUS ACTIVE
PURPOSE Directs the Joint Committee on Government and Finance to study the impacts of cost sharing, coinsurance, and specialty tier pricing for prescription medications, including (i) the impact of cost sharing, coinsurance, and specialty tier pricing on access to prescription medications for chronic health disorders and (ii) options for reducing any negative impacts of cost sharing, coinsurance, and specialty tier pricing, including but not limited to statutory limitations on cost-sharing obligations for prescription medications.
wisconsin
BILL # No known legislation existing or recently introduced.
wyoming
BILL # No known legislation existing or recently introduced.
|
|||||||
|
|||||||
|
|
|||||||
